Literature DB >> 16720794

Donepezil effects on cerebral blood flow in older adults with mild cognitive deficits.

Xiying Chen1, Vincent A Magnotta, Kevin Duff, Laura L Boles Ponto, Susan K Schultz.   

Abstract

Cerebral blood flow (CBF) was assessed during a verbal recall task using [(15)O]water positron emission tomography (PET) in older adults with mild cognitive deficits participating in a placebo-controlled donepezil trial. The placebo group demonstrated reduced CBF in the left frontal and temporal regions over the 6-month period, while those receiving donepezil did not. The placebo group's performance did not change on a list-learning task, while the donepezil group's performance improved, despite having had lower performance at intake. These findings suggest that donepezil treatment may be associated with a relative maintenance of CBF and improved list-learning.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16720794     DOI: 10.1176/jnp.2006.18.2.178

Source DB:  PubMed          Journal:  J Neuropsychiatry Clin Neurosci        ISSN: 0895-0172            Impact factor:   2.198


  8 in total

1.  Biomarkers in Alzheimer's disease drug development.

Authors:  Kaj Blennow
Journal:  Nat Med       Date:  2010-09-21       Impact factor: 53.440

2.  Cerebral blood flow and autoregulation: current measurement techniques and prospects for noninvasive optical methods.

Authors:  Sergio Fantini; Angelo Sassaroli; Kristen T Tgavalekos; Joshua Kornbluth
Journal:  Neurophotonics       Date:  2016-06-21       Impact factor: 3.593

Review 3.  The Black Book of Psychotropic Dosing and Monitoring.

Authors:  Alan F Schatzberg; DeBattista Charles
Journal:  Psychopharmacol Bull       Date:  2018-01-15

4.  Quantitative analysis of the effects of donepezil on regional cerebral blood flow in Alzheimer's disease by using an automated program, 3DSRT.

Authors:  Masaru Tateno; Seiju Kobayashi; Kumiko Utsumi; Hidetoshi Morii; Kazuki Fujii
Journal:  Neuroradiology       Date:  2008-05-16       Impact factor: 2.804

5.  Evaluation of older persons with mild cognitive deficits: potential utility of magnetic resonance imaging.

Authors:  Susan K Schultz; Vincent Magnotta; Kevin Duff; Laurie L Boles Ponto; David J Moser
Journal:  Ann Clin Psychiatry       Date:  2008 Oct-Dec       Impact factor: 1.567

6.  Broader considerations of higher doses of donepezil in the treatment of mild, moderate, and severe Alzheimer's disease.

Authors:  Camryn Berk; Marwan Sabbagh
Journal:  Int J Alzheimers Dis       Date:  2011-12-01

7.  Diagnosing Mild Cognitive Impairment (MCI) in clinical trials: a systematic review.

Authors:  Blossom Christa Maree Stephan; Thais Minett; Emma Pagett; Mario Siervo; Carol Brayne; Ian G McKeith
Journal:  BMJ Open       Date:  2013-02-04       Impact factor: 2.692

8.  Cholinergic Enhancement of Brain Activation in Mild Cognitive Impairment during Episodic Memory Encoding.

Authors:  Shannon L Risacher; Yang Wang; Heather A Wishart; Laura A Rabin; Laura A Flashman; Brenna C McDonald; John D West; Robert B Santulli; Andrew J Saykin
Journal:  Front Psychiatry       Date:  2013-09-17       Impact factor: 4.157

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.